Stefan O. Emdin - Concepedia

Author

Stefan O. Emdin

Umeå University

Also Known As

H Garmo, S Emdin, S O Emdin, S. EMDIN, S. Emdin, S. O. EMDIN, S. O. Emdin, S.O. Emdin, STEFAN EMDIN, STEFAN O. EMDIN

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Umeå University Lund University Malmö University University of Chicago Uppsala University Hospital

About

Stefan O. Emdin is an author at Umeå University specializing in medicine, breast cancer, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	1.8K
2	Biochemistry	8	8	577
3	Natural Sciences	5	5	255
4	Biology	5	5	293
5	Health Sciences	1	1	12

Stefan O. Emdin

Publications

Citations

H-Index

Page 1

	Year	Citations
Role of zinc in insulin biosynthesis Stefan O. Emdin, Guy Dodson, J. M. Cutfield, Diabetologia BiosynthesisBiochemistryBioactive MetalPhysiologyDiabetes	1980	254
Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast Lars Holmberg, Hans Garmo, Bengt Granstrand, Journal of Clinical Oncology	2008	254
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening Stefan O. Emdin, Bengt Granstrand, Anita Ringberg, Acta Oncologica	2006	232
Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial Fredrik Wärnberg, Hans Garmo, Stefan O. Emdin, Journal of Clinical Oncology	2014	226
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients Maria Stendahl, Åsa Kronblad, Lisa Rydén, British Journal of Cancer	2004	166
Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein Niels Hilmer Nielsen, Stefan O. Emdin, Jenny Cajander, Oncogene Breast OncologyCell RegulationMedicineRetinoblastoma ProteinBreast Cancer	1997	150
Tumor Specific VEGF-A and VEGFR2/KDR Protein are Co-expressed in Breast Cancer Lisa Rydén, Barbro Linderholm, Niels Hilmer Nielsen, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyTumor Specific Vegf-aMedicineVegfr2/kdr Protein	2003	119
Expression and Signaling Activity of Wnt-5a/Discoidin Domain Receptor-1 and Syk Plays Distinct but Decisive Roles in Breast Cancer Patient Survival Janna Dejmek, Karin Leandersson, Jonas Manjer, Clinical Cancer Research	2005	114
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis Sofie Svensson, Karin Jirström, Lisa Rydén, Oncogene Breast OncologyEndocrine-related CancerMedicineReceptor Tyrosine KinaseBreast Cancer	2005	112
Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects Stefan O. Emdin, Roger Stenling, Göran Roos Cancer Gastrointestinal OncologyCancer DetectionMedicineFlow Cytometric StudyPrognostic Value	1987	108

Page 1